Growth Metrics

NeuroPace (NPCE) Current Deferred Revenue (2020 - 2026)

NeuroPace's quarterly Current Deferred Revenue came in at $100000.0 in Q1 2026, down 85.71% year-on-year from $700000.0 in Q1 2025, and little changed quarter-over-quarter from $100000.0 in Q4 2025.

NeuroPace has reported Current Deferred Revenue for 5 years, with the latest figure at $100000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Current Deferred Revenue fell 85.71% year-over-year to $100000.0; the trailing twelve-month figure through Mar 2026 stood at $100000.0 (down 85.71% YoY), and the FY2025 full-year result was $100000.0, down 83.33% from the prior year.
  • Current Deferred Revenue for Q1 2026 stood at $100000.0, roughly flat from $100000.0 in the prior quarter.
  • The five-year high for Current Deferred Revenue was $1.1 million in Q4 2023, with the low at $100000.0 in Q4 2025.
  • Average Current Deferred Revenue over 4 years is $625500.0, with a median of $698000.0 recorded in 2024.
  • Year-over-year, Current Deferred Revenue retreated 13.0% in 2025 and sank 85.71% in 2026.
  • Tracing NPCE's Current Deferred Revenue over 4 years: stood at $1.1 million in 2023, then plunged by 44.95% to $600000.0 in 2024, then plunged by 83.33% to $100000.0 in 2025, then changed by 0.0% to $100000.0 in 2026.
  • The last three Current Deferred Revenue figures came in at $100000.0 (Q1 2026), $100000.0 (Q4 2025), and $600000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 NeuroPace 558.86 Mn 504.88 Mn 18.05 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 100,000.00
Dec 31, 2025 100,000.00
Sep 30, 2025 600,000.00
Jun 30, 2025 696,000.00
Mar 31, 2025 700,000.00
Dec 31, 2024 600,000.00
Sep 30, 2024 700,000.00
Jun 30, 2024 800,000.00
Mar 31, 2024 869,000.00
Dec 31, 2023 1.09 Mn
Jun 30, 2020 300,000.00